Skip to content
LifeAire Systems
Menu
  • Solutions
    • In Vitro Fertilization (IVF)
    • Healthcare & Hospitals
    • Life Sciences & Cell Gene Therapy
    • Transportation & Commercial
    • Senior Living
    • Dentistry
    • COVID-19
  • Products
    • Products Overview
    • Aire~HCX | Hospitals & Healthcare
    • Aire~IVF | In Vitro Fertilization
    • Aire~LSX | Life Science
    • Aire~LTCX | Long Term Care
    • Aire~Purity | Commercial Applications
    • Aire~VOC | Volatile Organic Compounds
    • Aire~IRMU | In Room Modular Unit
    • Aire~LifeLine | In-Line Gas Filtration
    • Aire~BioLite | UV Air Disinfection
    • Aire~BioMid | UV Air Disinfection
    • Patents
  • Services
    • Services Overview
    • Aire~Design™
    • Aire~Analysis
  • Published Research
  • News
  • About
    • The LifeAire Story
    • The LifeAire Difference for IVF Patients
    • Leadership
    • Advisors
    • LifeAire Centers of Excellence
    • Patents
    • Awards
    • Customer Testimonials
    • Podcasts & Presentations
    • Our Pure Air Guarantee
  • Contact Us

Day: March 19, 2019

Life Sciences

LifeAire Systems Hosts Discussion on the Harmful Impact of VOCs on Cell Culture Viability and Expression Rates in Cell and Gene Therapies

LifeAire Systems’ Founder and CEO, Dr. Kathryn C. Worrilow, is speaking at InterPhex 2019 in New York City to raise visibility to the cytotoxic role that airborne volatile organic compounds, …

© 2026 LifeAire Systems, LLC | All rights reserved. | Privacy Policy
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset